{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:42:56Z","timestamp":1795034576517,"version":"4.10.2"},"reference-count":15,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T00:00:00Z","timestamp":1511827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN201000003I"],"award-info":[{"award-number":["HHSN201000003I"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>The purposes of this work were to: (1) compare pharmacokinetic (PK) parameters for hydroxycarbamide in children receiving their first dose (HC<jats:sub>new<\/jats:sub>) <jats:italic>vs.<\/jats:italic> those receiving chronic therapy (HC<jats:sub>chronic<\/jats:sub>), (2) assess the external validity of a published PK dosing strategy, and (3) explore the accuracy of dosing strategies based on a limited number of HC measurements.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Utilizing data from two prospective, multicenter trials of hydroxycarbamide (Pharmacokinetics of Liquid Hydroxyurea in Pediatric Patients with Sickle Cell Anemia; NCT01506544 and Single\u2010Dose (SD) and Steady\u2010State (SS) Pharmacokinetics of Hydroxyurea in Children and Adolescents with Sickle Cell Disease), plasma drug concentration <jats:italic>vs.<\/jats:italic> time profiles were evaluated with a model independent approach in the HC<jats:sub>new<\/jats:sub> and HC<jats:sub>chronic<\/jats:sub> groups. Various predictive scenarios were analysed to evaluate whether systemic exposure with hydroxycarbamide could be accurately predicted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Absorption of hydroxycarbamide was rapid, variable and dose independent. Dose\u2010normalized peak plasma concentrations and drug exposure (AUC) were higher, and weight\u2010normalized apparent oral clearance was lower in the HC<jats:sub>new<\/jats:sub> group. We assessed a PK\u2010guided dosing strategy along with other predictive scenarios and found that inclusion of plasma samples only slightly improved the accuracy of AUC predictions when compared to a population\u2010based method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Children na\u00efve to hydroxycarbamide exhibit a different PK profile compared to children receiving chronic therapy. Accuracy of population\u2010based dosing is sufficient to target AUCs in individual patients. Further clearance\/bioavailability studies are needed to address the factors responsible for variability in the disposition of hydroxycarbamide.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.13426","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T10:56:51Z","timestamp":1504868211000},"page":"1478-1485","source":"Crossref","is-referenced-by-count":12,"title":["Hydroxycarbamide in children with sickle cell anaemia after first\u2010dose <i>vs<\/i>. chronic therapy: pharmacokinetics and predictive models for drug exposure"],"prefix":"10.1111","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2257-0421","authenticated-orcid":false,"given":"Jeremie H.","family":"Estepp","sequence":"first","affiliation":[{"name":"Departments of Hematology and Pathology St. Jude Children's Research Hospital  Memphis TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Wiczling","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics and Pharmacodynamics Medical University of Gda\u0144sk  Gda\u0144sk Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Moen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics St. Jude Children's Research Hospital  Memphis TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolian","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics St. Jude Children's Research Hospital  Memphis TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Marie","family":"Mack","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology University of Arkansas for Medical Sciences  Little Rock AR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Liem","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Stem Cell Transplant, Ann &amp; Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics Northwestern University Feinberg School of Medicine  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Panepinto","sequence":"additional","affiliation":[{"name":"Section of Pediatric Hematology\/Oncology Medical College of Wisconsin, and Children's Research Institute of the Children's Hospital of Wisconsin  Milwaukee WI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Children's Mercy Hospitals and Clinics  Kansas City MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kearns","sequence":"additional","affiliation":[{"name":"Arkansas Children's Research Institute Arkansas Children's Hospital  Little Rock AR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Neville","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Clinical Pharmacology and Medical Toxicology Arkansas Children's Hospital  Little Rock AR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011783"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.5.1533"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.303"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199834050-00002"},{"key":"e_1_2_9_6_1","first-page":"1685","article-title":"Pharmacokinetics of hydroxyurea 1,000\u00a0mg coated breakable tablets and 500\u00a0mg capsules in pediatric and adult patients with sickle cell disease","volume":"91","author":"Montalembert M","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-364190"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.11.002"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-146852"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.598"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12851"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000145"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-459-3_26"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00232.2013"},{"key":"e_1_2_9_15_1","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","article-title":"Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia [see comments]","volume":"79","author":"Charache S","year":"1992","journal-title":"Blood"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60355-3"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.13426","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.13426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T05:06:11Z","timestamp":1694667971000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.13426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1111\/bcp.13426"],"URL":"https:\/\/doi.org\/10.1111\/bcp.13426","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]}}}